Turkish food manufacturer Ulker Biskuvi slips after Q2 profit miss
** Shares in Ulker Bisküvi ULKER.IS drop almost 3% after the Turkey-based food manufacturer reported Q2 net profit below expectations
** Ulker Biskuvi announced Q2 net profit of 1.26 billion lira ($37.55 million) versus loss of 2.47 billion lira a year earlier but missed a consensus estimate by 25%
** "The stable Turkish lira as well as limited pricing took its toll on Ulker, slowing down the international revenue growth in lira terms and reducing investment returns", J.P.Morgan says
** J.P.Morgan says this leads the company to miss consensus estimates by around 25% at the earnings level
** The stock is the worst performer on Turkey's BIST 100 index .XU100 which is down 0.18%
($1 = 33.5590 liras)
Reporting by Canan Sevgili
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
